Cargando…

The biology of TREM receptors

Triggering receptors expressed on myeloid cells (TREMs) encompass a family of cell-surface receptors chiefly expressed by granulocytes, monocytes and tissue macrophages. These receptors have been implicated in inflammation, neurodegenerative diseases, bone remodelling, metabolic syndrome, atheroscle...

Descripción completa

Detalles Bibliográficos
Autor principal:	Colonna, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904274/ https://www.ncbi.nlm.nih.gov/pubmed/36750615 http://dx.doi.org/10.1038/s41577-023-00837-1

Ejemplares similares

TREM2 dependent and independent functions of microglia in Alzheimer’s disease
por: Hou, Jinchao, et al.
Publicado: (2022)

TREM2-Dependent Effects on Microglia in Alzheimer’s Disease
por: Zhou, Yingyue, et al.
Publicado: (2018)

TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria
por: N'Diaye, Elsa-Noah, et al.
Publicado: (2009)

Impaired Differentiation of Osteoclasts in TREM-2–deficient Individuals
por: Cella, Marina, et al.
Publicado: (2003)

Function of TREM1 and TREM2 in Liver-Related Diseases
por: Sun, Huifang, et al.
Publicado: (2020)

TREM Receptors Connecting Bowel Inflammation to Neurodegenerative Disorders
por: Natale, Gianfranco, et al.
Publicado: (2019)

The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis
por: Genua, Marco, et al.
Publicado: (2014)

Aminophospholipids are signal-transducing TREM2 ligands on apoptotic cells
por: Shirotani, Keiro, et al.
Publicado: (2019)

Triggering Receptor Expressed on Myeloid Cells (TREM)-2 Impairs Host Defense in Experimental Melioidosis
por: Weehuizen, Tassili A. F., et al.
Publicado: (2016)

The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
por: Xiang, Xianyuan, et al.
Publicado: (2018)

TREM2 triggers microglial density and age‐related neuronal loss
por: Linnartz‐Gerlach, Bettina, et al.
Publicado: (2018)

TREM2 in Neurodegenerative Diseases
por: Jay, Taylor R., et al.
Publicado: (2017)

Microglia control small vessel calcification via TREM2
por: Zarb, Yvette, et al.
Publicado: (2021)

TREM2 function impedes tau seeding in neuritic plaques
por: Leyns, Cheryl E.G., et al.
Publicado: (2019)

TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activation
por: Iizasa, Ei’ichi, et al.
Publicado: (2021)

Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism
por: Song, Wilbur M., et al.
Publicado: (2018)

Role of TREM1-DAP12 in Renal Inflammation during Obstructive Nephropathy
por: Tammaro, Alessandra, et al.
Publicado: (2013)

TREM2 expression in the brain and biological fluids in prion diseases
por: Diaz-Lucena, Daniela, et al.
Publicado: (2021)

TREM2 in CNS homeostasis and neurodegenerative disease
por: Painter, Meghan M., et al.
Publicado: (2015)

Behavioral and transcriptomic analysis of Trem2-null mice: not all knockout mice are created equal
por: Kang, Silvia S, et al.
Publicado: (2018)

TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model
por: Wang, Yaming, et al.
Publicado: (2015)

TREM-2 promotes macrophage survival and lung disease after respiratory viral infection
por: Wu, Kangyun, et al.
Publicado: (2015)

Targeting Mononuclear Phagocyte Receptors in Cancer Immunotherapy: New Perspectives of the Triggering Receptor Expressed on Myeloid Cells (TREM-1)
por: Raggi, Federica, et al.
Publicado: (2020)

Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms
por: Kober, Daniel L, et al.
Publicado: (2016)

High‐affinity interactions and signal transduction between Aβ oligomers and TREM2
por: Lessard, Christian B, et al.
Publicado: (2018)

TREM-1, TREM-2 and their association with disease severity in patients with COVID-19
por: Fan, Ruyue, et al.
Publicado: (2023)

TMEM59 interacts with TREM2 and modulates TREM2-dependent microglial activities
por: Liu, Zhaoji, et al.
Publicado: (2020)

sTREM-1 is a specific biomarker of TREM-1 pathway activation
por: Jolly, Lucie, et al.
Publicado: (2021)

TREM2 regulates innate immunity in Alzheimer’s disease
por: Li, Jiang-Tao, et al.
Publicado: (2018)

TREM-1; Is It a Pivotal Target for Cardiovascular Diseases?
por: Kouassi, Kouassi T., et al.
Publicado: (2018)

New insights into the role of TREM2 in Alzheimer’s disease
por: Gratuze, Maud, et al.
Publicado: (2018)

Exploring the Impact of TREM2 in Tumor-Associated Macrophages
por: Khantakova, Darya, et al.
Publicado: (2022)

TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers
por: Del-Aguila, Jorge L., et al.
Publicado: (2019)

The role of triggering receptor expressed on myeloid cells-1 (TREM-1) in central nervous system diseases
por: Zhang, Chunyan, et al.
Publicado: (2022)

Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
por: Ulrich, Jason D, et al.
Publicado: (2014)

The Triggering Receptor Expressed on Myeloid Cells 2: “TREM-ming” the Inflammatory Component Associated with Alzheimer's Disease
por: Rohn, Troy T.
Publicado: (2013)

Role of TREM-1 in pulmonary tuberculosis patients- analysis of serum soluble TREM-1 levels
por: Feng, Jia-Yih, et al.
Publicado: (2018)

Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer’s disease model
por: Wang, Shoutang, et al.
Publicado: (2020)

TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy
por: Leyns, Cheryl E. G., et al.
Publicado: (2017)

TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
por: Wang, Yaming, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3lej7ct2cdnooe8du84qr0s6hn